Celltrion reported 623.7 billion won ($521 million) in net profit in 2021, up 20.1 percent on year, according to a regulatory filing on Wednesday.
Celltrion said Monday Phase 1 clinical trials of an inhalable form of Regkirona produced meaningful results confirming safety.
Regkirona, Korea’s first Covid-19 treatment, won two-year temporary use authorization from regulators in Switzerland, developer Celltrion said Friday.
Samsung Biologics will manufacture an AstraZeneca cancer treatment under a contract manufacturing organization (CMO) deal, strengthening its strategic partnership with the British pharmaceutical firm.
Celltrion Healthcare has signed deals for Regkirona, Korea's first Covid-19 treatment, with 18 countries.
Hyundai Bioscience is developing a Covid-19 treatment that will remain effective for all kinds of variants, the company said.
Regkirona, Korea’s first Covid-19 treatment, won conditional use approval from regulators in Australia, manufacturer Celltrion said Tuesday.
CrystalGenomics said Thursday that animal tests of its oral Covid-19 treatment candidate confirmed its effectiveness against the Delta variant.
Celltrion Healthcare has signed agreements with nine European countries for the distribution of Regkirona, Korea's first Covid-19 treatment.
Regkirona, Korea’s first Covid-19 treatment, won conditional use approval from regulators in Peru, Celltrion said Monday.
Korea JoongAng Daily Sitemap
